Empire State Review Contributor•
In a significant development for migraine sufferers, a recent study suggests that glucagon-like peptide-1 (GLP-1) receptor agonists—medications primarily used to treat type 2 diabetes and obesity—may also substantially reduce the…
Empire State Review Contributor•
BETHESDA, MD — On June 9, 2025, the National Institutes of Health (NIH) released a comprehensive report detailing significant advancements in medical robotics aimed at enhancing patient care. The report…
Empire State Review Contributor•
In a groundbreaking advancement for cancer care, NHS England has officially rolled out a “liquid biopsy” blood test designed to detect lung and breast cancer in its early stages. This…
Empire State Review Contributor•
Healthcare professionals and public health advocates are expressing serious concerns over Robert F. Kennedy Jr.’s recent decision to remove COVID-19 booster shots from the recommended immunization schedule, particularly due to…
Empire State Review Contributor•
In a major shift to U.S. public health policy, the Centers for Disease Control and Prevention (CDC) announced on May 27, 2025, that it will no longer recommend COVID-19 vaccinations…
Empire State Review Contributor•
The measles outbreak in Texas, which has become one of the most severe in the United States in over two decades, is showing signs of subsiding. However, health officials warn…
Empire State Review Contributor•
As flu season approaches, New York’s healthcare system is bracing for a potential surge in respiratory illnesses, including influenza, COVID-19, and respiratory syncytial virus (RSV). These illnesses, which are common…
Empire State Review Contributor•
A groundbreaking clinical trial funded by Stand Up To Cancer (SU2C) and led by Memorial Sloan Kettering Cancer Center (MSK) has demonstrated that immunotherapy may eliminate the need for…
Empire State Review Contributor•
In a significant breakthrough for Alzheimer’s disease treatment, a new drug developed by the pharmaceutical company BioGenix, named NeuroCure, has shown promising results in early-stage clinical trials. The drug targets…
Empire State Review Contributor•
A groundbreaking new treatment for Alzheimer’s disease has shown promising results in early-stage clinical trials, offering renewed hope for millions of people battling the debilitating effects of the disease. Developed…